Background: In recent years, government initiatives have proposed that patient self-care should serve as a key resource in response to the anticipated increase in global demand for health care. However, if patients are to be empowered as self-carers, barriers to engagement must be identified and overcome. Anaphylaxis is an increasingly common life-threatening allergic reaction. Patients at risk of anaphylaxis are prescribed epinephrine auto-injectors and play a crucial role in delivering their own care and management of this condition. One key recommendation is that patients routinely carry an epinephrine auto-injector with them and deploy the device when needed. However, only a small proportion of patients that require epinephrine actually receive it.
Objective: To explore the reasons why patients who have been prescribed epinephrine auto-injectors fail to adhere to self-care and management recommendations.
Methods: In-depth interviews with 15 adults who have been prescribed epinephrine auto-injectors were carried out to explore the barriers that exist in the provision of effective self-care and management of anaphylaxis.
Results: Inconsistent health professional advice, perceived stigma of carrying a 'weapon-like' device, poor device design and limited patient training were identified as barriers to carriage or use. Patients were reluctant to carry devices in public because of perceived and observed stigma and suspicion. They were happy to ignore expiry dates, and some participants were confident that the emergency services would provide them with the appropriate care they needed, and therefore, did not carry the device in urban areas.
Conclusions And Clinical Implications: Improved training of patients, the public and health professionals around both the carriage and use of auto-injectors are areas for urgent attention if improved levels of self-care are to be attained. The design of epinephrine auto-injectors should also receive attention as patients often fail to carry them owing to size and aesthetics.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1471-6712.2012.01045.x | DOI Listing |
Clin Exp Allergy
January 2025
Service de Pneumologie A, APHP, Hôpital Bichat, Paris, France.
Adrenaline is the first line treatment for anaphylaxis and adrenaline auto-injectors (AAI) allow reliable, safe and ergonomic administration in the community. However, AAIs have significant limitations and adrenaline is often not used in anaphylaxis. Innovations to administer adrenaline via alternative routes may potentially improve usage rates and treatment effectiveness.
View Article and Find Full Text PDFBMJ Paediatr Open
November 2024
University of Southampton, Southampton, UK.
Objective: To investigate awareness and implementation of the Spare Pens (ie, adrenaline auto-injectors (AAIs)) scheme in primary and secondary schools in two regions in Wales.
Design: A cross-sectional pilot study employing a mixed research methods approach was carried out.
Setting And Participants: State primary and secondary schools within Swansea and Pembrokeshire regional authorities were invited to take part.
Clin Exp Allergy
January 2025
National Heart and Lung Institute, Imperial College London, London, UK.
Clin Exp Allergy
November 2024
National Heart and Lung Institute, Imperial College London, London, UK.
Curr Allergy Asthma Rep
November 2024
Department of Allergy and Immunology, Texas Children's Hospital, Houston, TX, USA.
Purpose Of Review: To discuss if all patients who use self-injectable epinephrine outside the hospital setting require immediate emergency care.
Recent Findings: Prior to 2023, anaphylaxis management guidance universally recommended that patients who use self-injectable epinephrine outside of the hospital or clinic setting immediately activate emergency medical services and seek further care. Additional food-induced anaphylaxis management recommendations specified that all patients always carry 2 auto-injector devices and give a second dose of epinephrine if there was not immediate response within 5 min of injection.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!